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The Dbf4/Drf1-dependent kinase (DDK) is required for the
initiation of DNA replication in eukaryotes. Another protein,
Claspin, mediates the activation of a cellular checkpoint
response to stalled replication forks and is also a regulator of
replication. In this study, we found that DDK phosphorylates
Claspin in vitro and forms a nuclear complex containing Cdc7,
Drf1, and Claspin in Xenopus egg extracts. In addition, purified
Claspin andDDK are capable of a direct in vitro interaction.We
identified a conserved binding site on Claspin required for its
interaction with DDK. This site corresponds to the first of two
sequence repeats in the Chk1-binding domain of Claspin. Fur-
thermore, we have established that two amino acids in this
motif, Asp861 and Gln866, are essential for the interaction
between Claspin and DDK. We found that mutant forms of
Claspin incapable of interacting with DDK are still able to asso-
ciate with and activate Chk1 in response to DNA replication
blockages. However, Claspin-depleted egg extracts that have
been reconstituted with thesemutants of Claspin undergoDNA
replication more slowly. These findings suggest that the inter-
action ofDDKwithClaspinmediates a checkpoint-independent
function of Claspin related to DNA replication.
The maintenance of genomic stability is of paramount
importance to living organisms. For example, proliferating cells
must ensure the fidelity of chromosomal DNA replication. To
accomplish this task, eukaryotic organisms have evolved a
highly ordered series of steps to carry out DNA replication as
well as a system of checkpoints to monitor the integrity of this
process.
The stepwise process of eukaryotic DNA replication begins
with the formation of prereplication complexes at replication
origins (1, 2). The conversion of the prereplication complexes
into active replication forks is promoted by the action of two
kinases, theSphasecyclin-dependentkinaseandtheDbf4/Drf1-
dependent kinase (DDK).2 In higher eukaryotes, there are two
versions of DDK that consist of the kinase subunit Cdc7 and
either Dbf4 or Drf1 as regulatory subunits (3–5). Cdc7 is con-
stitutively expressed throughout the cell cycle, but its kinase
activity is dependent upon associationwith eitherDbf4 orDrf1.
Hence, the relationship between Cdc7 and Dbf4/Drf1 is func-
tionally analogous to the cyclin-dependent kinase/cyclin rela-
tionship (5, 6). In early Xenopus embryos, Drf1 is the primary
Cdc7-binding partner that drives replication (7, 8). The most
well established target of DDK activity is the MCM2–7 com-
plex, which is an important constituent of the putative replica-
tive helicase. DDK phosphorylates multiple components of
the MCM complex (9–11). Moreover, the action of DDK is
required for the recruitment of Cdc45 to chromatin (12, 13). It
is thought that Cdc45 stimulates replicative helicase activity,
which allows binding of DNApolymerases and other DNA rep-
lication elongation factors to origins (14–17).
Cells frequently encounter barriers during the course of
DNA replication. Cells respond to the resulting stalled replica-
tion forks mainly by employing the ATR-Chk1 checkpoint
pathway (18, 19). ATR is a sensor kinase that becomes activated
in response to stalled replication forks and thereby transduces
signals through the effector kinase Chk1. These signaling steps
lead to the prevention of the inappropriate entry into mitosis
and the inhibition of late replication origin firing (18, 19). ATR
directly phosphorylates Chk1 by a mechanism that depends on
the checkpoint mediator protein Claspin (20–22). Besides its
well established function inmediating the activation of Chk1 in
response to replication stress, Claspin also has roles in the reg-
ulation of unperturbedDNA replication and in the stabilization
of disrupted replication forks (23–25). Claspin is a component
of both normal and stalled replication forks. It interacts with a
number of replication factors, including Cdc45, replication fac-
tor C, replication protein A, and DNA polymerase , and is
necessary for a normal rate of fork progression (23–27). The
association of Claspin with chromatin depends on Cdc45 and
occurs at approximately the same time as polymerase  (23).
Likewise, the yeast ortholog of Claspin, Mrc1, moves with the
replication fork and is necessary for a normal rate of DNA rep-
lication (28–33).
Despite the inhibition of late origin firing under conditions of
checkpoint-inducing replication stress, the Cdc7/Drf1 kinase
remains active (34–36). Several lines of evidence indicate that
DDKmay play a role in the regulation of checkpoint responses
inmetazoan systems. Drf1 accumulates on replication-arrested
chromatin in anATR- andClaspin-dependentmanner inXeno-
pus egg extracts (34). In addition, human Cdc7 has been shown
to phosphorylate and interactwith humanClaspin inHeLa cells
(37). Moreover, when Cdc7 is knocked down by small interfer-
ing RNA, mammalian cells are more sensitive to agents that
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elicit replication stress, such as hydroxyurea. These Cdc7-ab-
lated cells are defective in the checkpoint-associated phosphor-
ylation of Chk1 andClaspin (37). Finally, the ectopic addition of
excess Dbf4-Cdc7 toXenopus egg extracts or overexpression of
Dbf4 in HeLa cells is able to down-regulate the ATR-Chk1
pathway signaling elicited by agents that induce replication
stress (36).
For these reasons, we sought to examine the potential role of
DDK in response to replication stress by further examining the
relationship betweenDDKand the replication-monitoring pro-
tein Claspin. In this study, we established that DDK phosphor-
ylates and interacts with Claspin in Xenopus egg extracts. Fur-
thermore, we precisely mapped the site of this interaction to an
evolutionarily conserved protein motif on Claspin. We found
that two amino acids located within the region of Claspin
shown to be essential for binding and activating Chk1 were
required for the interaction with DDK. Interestingly, however,
we demonstrate that this interaction is not required for Claspin
to mediate activation of Chk1. These findings suggest that
interaction with DDK reflects a checkpoint-independent func-
tion of Claspin.
EXPERIMENTAL PROCEDURES
Xenopus Egg Extracts—Interphase egg extracts were treated
with 50 g/ml annealed (dA)70-(dT)70 (pA-pT) to activate
checkpoint responses as described previously (20). To produce
chromatin containing DNA replication blocks, the extracts
were incubated with demembranated sperm nuclei (3000–
4000/l) and 50 g/ml aphidicolin.
Antibodies—Immunodepletion and immunoblotting of
Claspin were performedwith antibodies raised against residues
232–606 of Claspin (38). The anti-Claspin immunoprecipita-
tions (IPs) in this paper were carried out with antibodies gen-
erated against residues 1–464 of Claspin (20). Anti-Drf1, anti-
Cdc7, anti-Plx1, anti-replication protein A 70, and anti-Chk1
antibodies were described previously (23, 34, 39, 40). Anti-GST
(Santa Cruz Biotechnology), anti-FLAGM2 (Sigma), and anti-
bodies that detect phosphorylated Ser344 of Xenopus Chk1
(Cell Signaling Technology) were purchased from commercial
sources. Anti-Scc2 serum (41) was a generous gift of T. Taka-
hashi (Osaka University, Osaka, Japan).
Recombinant Proteins—GST-fused Claspin fragments 847–
903 and 847–903(2AG) were described previously (42). DNA
sequences for additional GST-fused Claspin fragments (amino
acids 1–258, 258–518, 518–775, 776–851, 847–962, 961–
1078, 1076–1285, 776–877, 776–867, 776–856, 847–877,
857–903, 868–903, 878–903, 902–961, 776–1078, and 878–
961) were cloned into the pGEX-2T expression vector using
PCR-based methods. Sequences encoding the minimal DDK
binding site (residues 856–867) and point mutants thereof
(D861E, Q866K, and D861E/Q866K) were cloned into
pGEX-2T by producing oligonucleotide linkers that create 5
BamHI and 3 EcoRI cohesive ends upon annealing. These oli-
gonucleotides were subsequently ligated into the linearized
vector prepared with the appropriate restriction sites. Con-
structs for fragments of human Claspin (HuCKBD1, residues
908–919; HuCKBD2, residues 937–948; and HuCKBD3, resi-
dues 974–985) were prepared in a similar manner. The above
GST-fused peptides were expressed in Escherichia coli BL21
CodonPlus (RIL) cells and purified with glutathione-agarose
beads. Site-directed mutagenesis using the QuikChange kit
(Stratagene) was performed to create the D861E, Q866K, and
D861E/Q866K mutants with pFastBac-His6-Claspin-FLAG
(full-length) and pGEX-2T(776–1078) as templates. For bacu-
lovirus expression in Sf9 insect cells, the sequence encoding
full-length Xenopus Drf1 was cloned into pFastBacHTa by
standard methods. Recombinant baculoviruses were created
using the Bac-to-Bac system (Invitrogen). Wild-type Chk1-
GST-His6 protein was expressed and purified in Sf9 insect cells
as described previously (20). Full-length Claspin proteins were
expressed in Sf9 insect cells and purified with M2 anti-FLAG-
agarose beads (Sigma) and eluted with 3 FLAG peptide
(Sigma) in HEPES-buffered saline. The recombinant Xenopus
DDK complex was expressed in Sf9 cells that were co-infected
with baculoviruses encoding His6-Drf1 and a cellulose-binding
domain (CBD)-tagged version of Xenopus Cdc7 (a gift of Dr.
James Maller, U. of Colorado, Denver) (43). The complex was
purified with nickel-agarose beads according to methods
described previously (20).
Direct Binding Assay of the DDK-Claspin Interaction—Cel-
lulose resin (Sigmacell 20) was hydrated in binding buffer (10
mM HEPES-KOH, pH 7.5, 150 mM NaCl, 0.5% Triton X-100,
and 5 mM EGTA) and washed several times to remove smaller
cellulose fibers. The cellulose was preblocked with binding
buffer supplemented with 20 mg/ml bovine serum albumin for
30 min at 4 °C. Recombinant His6-Claspin-FLAG and/or His6-
Drf1/CBD-Cdc7 was incubated for 30 min at 4 °C in binding
buffer supplemented with 1 mM dithiothreitol; 1 mM phenyl-
methylsulfonyl fluoride; 10 g/l each of pepstatin, chymosta-
tin, and leupeptin; and 2 mg/ml bovine serum albumin. Next,
blocked cellulose (15 l) was added to each reaction, and the
incubation was continued for 25 min at 4 °C with agitation.
Finally, the cellulose was washed five times with binding buffer
and subsequently resuspended and boiled in 20 l of SDS-
PAGE sample buffer.
Immunoprecipitations, Immunodepletions, and GST Pull-
downs—Interphase immunoprecipitations were carried out
according to previously defined methods (34). Immunodeple-
tions of Claspin from extracts as well as GST pulldowns from
extracts were performed as in an earlier work (20).
Immunoprecipitation from Nuclear Lysates, Isolation of
Whole Nuclei from Extracts, and Replication Assays—Nuclear
IPs were performed by incubating 100 l (per IP reaction) of
extracts lacking or containing aphidicolin (4,000 nuclei/l) for
65min at room temperature and subsequently centrifuging the
extracts through 1 ml of ice-cold sucrose cushion (20 mM
HEPES-KOH, pH 7.5, 1 M sucrose, 80 mM KCl, 2.5 mM potas-
sium gluconate, and 10mMmagnesium gluconate) at 6,100 g
for 5min at 4 °C. The supernatant was removed, leaving a loose
pellet, to which another 500 l of sucrose cushion was added.
The sample was centrifuged again as above. The supernatant
was removed, and 25l of high salt lysis buffer (10 mMHEPES-
KOH, pH 7.5, 300 mM NaCl, 2.5 mM EGTA, 0.1% CHAPS, and
0.5% Nonidet P-40) was added to resuspend the pellets. The
samples were incubated for 10 min at 4 °C, diluted 4-fold with
75 l of 20 mM HEPES-KOH (pH 7.5) to reduce the salt con-
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centration, and subsequently centrifuged at 10,000 rpm for 10
min at 4 °C. For immunoprecipitations, the supernatant was
incubated with agitation at 4 °C for 1 h with Affiprep protein A
beads (Bio-Rad) that had been coatedwith the appropriate anti-
bodies. The beads were then washed four times with a buffer
containing 10 mM HEPES-KOH (pH 7.5), 80 mM NaCl, 2.5 mM
EGTA, 20 mM -glycerolphosphate, and 0.1% Nonidet P-40
and finally boiled in SDS-PAGE sample buffer. Whole nuclei
were obtained by centrifuging 25 l of extracts (mock de-
pleted or Claspin-depleted) twice through a 500-l sucrose
cushion as described above and then resuspending and boil-
ing the pellets in 20 l of SDS-PAGE sample buffer. Assays of
chromosomal DNA replication in egg extracts were per-
formed with [-32P]dATP as described previously (23).
RESULTS
DDK Forms a Stable Complex with Claspin in S Phase Egg
Extracts—An active form of the kinase Cdc7 can be isolated
from interphase Xenopus egg extracts by immunoprecipitating
the Drf1 protein (34). In the course of testing substrates for this
kinase activity, we observed that Cdc7 was able to phosphory-
late recombinant full-length His6-Claspin-FLAG protein in
vitro (supplemental Fig. S1, lane 3). This result led us to ask
whether Drf1 and Claspin can interact with one another in egg
extracts. To this end, we subjected interphase egg extracts to
immunoprecipitation with either anti-Drf1 or anti-Claspin
antibodies and then immunoblotted the immunoprecipitates
for Claspin and Drf1, respectively. These extracts were also
incubated in the absence or presence of the checkpoint-induc-
ing DNA oligonucleotides (dA)70-(dT)70. We could easily de-
tect Claspin in anti-Drf1 immunoprecipitates and vice versa.
These interactions were not affected by the presence of (dA)70-
(dT)70 (Fig. 1A). These results are consistent with studies on
human Claspin (37).
To examine this finding in greater detail, we also prepared
from interphase egg extracts lysates of replicating nuclei in
which we had eluted proteins from chromatin by salt treat-
ment. We immunoprecipitated these lysates with anti-Claspin,
anti-Drf1, and anti-Cdc7 antibodies and then immunoblotted
for all three proteins. In these experiments, we also found that
Claspin, Cdc7, and Drf1 formed a specific complex (Fig. 1B). In
addition, we observed that the formation of this complex was
not affected by aphidicolin, a drug that causes the formation of
stalled DNA replication forks in egg extracts. Recently, Cdc7
and Drf1 have been shown to form a stable complex with the
cohesin loading protein Scc2 in Xenopus egg extracts. More-
over, this interaction is required for the loading of the cohesin
complex onto chromatin during replication (41). In our exper-
iments, we observed that Scc2 and Claspin also associate with
each other in egg extracts in both the absence and the presence
of aphidicolin (Fig. 1B).
Next, we sought to determine whether the interaction
between DDK and Claspin was direct. For this purpose, we
performed in vitro binding assays with recombinant DDK and
Claspin. To prepare recombinant Xenopus DDK, we co-ex-
pressed His6-Drf1 and CBD-tagged Cdc7 in Sf9 insect cells and
then purified the complex with nickel-agarose beads. We then
incubated the purified DDK complex with recombinant full-
length His6-Claspin-FLAG or buffer alone. We also incubated
His6-Claspin-FLAG without DDK as a control. Finally, we
added cellulose resin to the incubations to isolate CBD-Cdc7
FIGURE 1. Claspin forms a complex with Cdc7 and Drf1 (DDK) in Xenopus
egg extracts. A, IPs with control (Mock), anti-Drf1, and anti-Claspin antibod-
ies were prepared from nuclei-free interphase egg extracts lacking or con-
taining (dA)70-(dT)70 (pA-pT) and immunoblotted for Claspin, Drf1, Cdc7, and
Plx1. Lanes 1 and 2depict 2%of pre-IP extracts. B, interphase extracts contain-
ing sperm nuclei (4,000/l) were incubated in the absence or presence of
aphidicolin (APH). Nuclear lysates were prepared and immunoprecipitated
with control (Mock), anti-Drf1, anti-Claspin, and anti-Cdc7 antibodies. These
immunoprecipitates were immunoblotted for Scc2, Claspin, Drf1, and Cdc7.
The Claspin immunoblots are presented as both long and short film expo-
sures. Lane1 is analiquotof interphaseeggextract, and lanes 2and3 show2%
of the pre-IP nuclear lysate lacking or containing aphidicolin. C, in vitro bind-
ing assays for the interaction of His6-Drf1/CBD-Cdc7 (DDK) and His6-Claspin-
FLAG. Full-length His6-Claspin-FLAG (lanes 2 and 3) or buffer alone (lane 4)
was incubated in the absence (lane 2) or presence of His6-Drf1/CBD-Cdc7
(lanes 3 and 4). Cellulose pulldowns were immunoblotted for Claspin, Drf1,
and Cdc7. Lane 1 shows 10% of the reaction in lane 3 before cellulose was
added.
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and its associated His6-Drf1 partner. We found that, in the
presence ofDDK,Claspin associatedwith the cellulose at a level
significantly above that in the control incubation containing
only His6-Claspin-FLAG (Fig. 1C, lanes 2 and 3). Therefore, we
conclude that the interaction between Claspin and DDK
appears to be direct.
Mapping a DDK-binding Site on Claspin—To characterize
further the interaction betweenDDK andClaspin, we sought to
identify the minimal region of Claspin that is required for this
binding. For this purpose, we first constructed a series of seven
GST-fused Claspin fragments that spanned the entirety of the
protein. Immunoprecipitations of Drf1 were carried out with
interphase extracts that had been
supplemented with these GST-
Claspin protein fragments. We
found that Drf1 strongly interacted
with the Claspin fragment contain-
ing amino acids 847–962 (Fig. 2A,
lane 11, and supplemental Fig. S2A).
There was also a weak interaction of
Drf1 with the fragment containing
amino acids 258–518 (supplemen-
tal Fig. S2A, lane 5).
Subsequently, we focused on the
847–962 fragment, both because
this interaction was very strong and
because this fragment contains the
Chk1-binding domain (CKBD), a
region required for the binding and
activation of Chk1 (42). The CKBD
of Claspin is composed of two
repeat sequences, each containing
serines that are phosphorylated
during a replication checkpoint
response. To more finely map the
sequence that is required for
Claspin to associate with Drf1, we
prepared a series of overlapping
GST-fused Claspin peptide frag-
ments ranging from amino acids
776 to 903. We found that peptide
fragments starting at position 776
and ending at or before amino acid
856 could not interact with Drf1
(Fig. 2, B and D, and supplemen-
tal Fig. S2B). Conversely, Claspin
fragments starting at or before resi-
due 856 could associate with Drf1,
whereas there was no binding of the
868–903 and 878–903 fragments
(Fig. 2, B and D, and supple-
mental Fig. S3). Thus, the region
comprising amino acids 856–867 of
Claspin is required for this interac-
tion (Fig. 2D). Interestingly, this
region corresponds to the first
repeat of the CKBD (856–867).
Notably, fragments containing the
second CKBD repeat (amino acids 887–898) failed to bind to
Drf1. To ascertain whether this minimal region was sufficient
for the interaction with DDK, we constructed a GST fusion
protein containing only residues 856–867 fromClaspin.When
we tested this fragment in the binding assay, we could readily
observe binding to Drf1 (Fig. 2C, lane 7). Thus, residues 856–
867 of Claspin are both necessary and sufficient for recognition
of Drf1.
It is striking that only the first CKBD repeat and not the
second one could interact with Drf1, given that only two amino
acids (namely, aspartate 861 and glutamine 866) are different
between the repeats (Fig. 3C). Some Claspin homologs, includ-
FIGURE 2. The region of Claspin required for interaction with DDKmaps to the first repeat sequence of
the CKBD. A, interphase egg extracts containing the indicated GST-Claspin fragments or GST alone were
immunoprecipitated with anti-Drf1 (D) or control (mock,M) antibodies and immunoblotted for Drf1 and GST.
The top arrow denotes a cross-reacting IgG band. Lane 1 depicts 2% of the pre-IP extract. Input levels for the
recombinantpeptides are shown in supplemental Fig. 2A.B, interphase, nuclei-freeeggextracts containing the
indicated GST-Claspin fragments or no recombinant protein were immunoprecipitated with anti-Drf1 (D) or
control (M) antibodies and immunoblotted for Drf1 and GST. Lane 19 depicts an aliquot of pre-IP extract. Input
levels (2%of thepre-IP extracts) for the recombinantpeptides are shown in supplemental Fig. 2B.C, interphase,
nuclei-free egg extracts containing GST-Claspin(776–856), GST-Claspin(776–867), GST-Claspin(856–867),
GST-Claspin(856–867)-Q866K, or no recombinant protein were immunoprecipitated with anti-Drf1 (D) or
control (M) antibodies and immunoblotted for Drf1 andGST (lanes 2–11). Lane 1depicts an aliquot of the initial
extract. Lanes 12–16 represent 2% of the pre-IP extracts containing the recombinant peptides listed above.
D, top panel, a schematic depiction of several known domains of Claspin. The domains are the replication
fork-interacting domain (RFID), the first and second repeats of the Chk1-binding domain (CKBD), and the
nuclear localization sequence (NLS). Bottom panel, a summary of the abilities of Claspin peptide fragments to
bind DDK.
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ing human Claspin, have three repeats instead of the two found
in Xenopus laevis (44, 45). When we compared CKBD repeat
sequences across a selection ofmetazoanClaspin homologs, we
noticed that these two positions displayed the most variability
(Fig. 3C). We initially focused on the position containing gluta-
mine 866, which changes from a glutamine to a lysine in the
second Xenopus repeat sequence. This variation represents a
difference in charge. By contrast, the position corresponding to
aspartate 861 contains a similar acidic residue (glutamate) in
the second CKBD repeat.
We constructed a GST-fused version of the 856–867 frag-
ment of Claspin in which glutamine 866 was changed to lysine
(hereafter referred to as the Q866K mutant). Upon testing this
mutated fragment, we observed that binding toDrf1 was signif-
icantly reduced but not completely abolished relative to the
original fragment (Fig. 2C, lane 9, and supplemental Fig. S4A).
Next, we proceeded to change aspartate 861 to glutamate (to
generate the D861E mutant). We also prepared the D861E/
Q866K double mutant (referred to as E/K). In the context of
the 856–867 fragment, the D861E
mutant displayed a more marked
reduction of binding to Drf1 in
comparison with the Q866K mu-
tant. Moreover, the double E/K
mutation essentially abolished the
interaction with Drf1 (supplemen-
tal Fig. S4A). We observed similar
results in a larger Claspin GST-
fused fragment (776–1078) that
contains the entire CKBD and is by
itself sufficient to rescue activation
of Chk1 in Claspin-depleted ex-
tracts (supplemental Fig. S4B) (24).
Finally, we decided to test the
capacity of thesemutants to interact
with DDK in the context of the
full-length Claspin protein. We
expressed and purified FLAG-
tagged recombinant versions of
wild-type, D861E, Q866K, and E/K
full-length Claspin proteins from
insect cells using a baculovirus pro-
tein expression system. The full-
length proteins followed the same
pattern as the smaller Claspin frag-
ments in that binding of the Q866K
mutant to Drf1 was reduced,
whereas binding of theD861E single
mutant and the double E/K binding
was nearly eliminated (Fig. 3A).
Because the Claspin CKBD se-
quences are well conserved across
metazoans, we decided to test
whether these amino acid sites were
important in the human ortholog of
Claspin. At the amino acid position
equivalent to aspartate 861 in Xeno-
pus Claspin, the human Claspin
CKBD repeats contain the residues aspartate, asparagine, and
alanine in the first, second, and third repeat, respectively.
Accordingly, we expressed and purified the three human
Claspin CKBD repeats as GST-fused peptides, added them to
Xenopus egg extracts, and assayed binding to Drf1 by immuno-
precipitating with anti-Drf1 antibodies as above. We observed
that the first human Claspin CKBD repeat (HuCKBD1) bound
efficiently to Drf1, whereas the second and third repeats
(HuCKBD2 and huCKBD3) did not bind at all (Fig. 3B, lanes
8–10). These findings suggest that theDDK-binding domain of
Claspin may be conserved across metazoan species.
The Interaction of Claspin with DDK Is Separable from Its
Role in Mediating the Activation of Chk1—Because we have
determined that the region of Claspin that interacts with DDK
also encompasses a key portion of its binding domain for Chk1,
we decided to compare the ability of Claspin to associate with
DDK versus Chk1. We first tested whether or not Chk1 could
bind to mutants that were defective for the interaction with
DDK. To this end, we performedGSTpulldownswith our array
FIGURE 3. Identification of conserved sites in Claspin required for interaction with DDK. A, interphase,
nuclei-free egg extracts containing full-length versions of wild-type His6-Claspin-FLAG, His6-Claspin-FLAG-
Q866K, His6-Claspin-FLAG-D861E, His6-Claspin-FLAG-E/K, or no recombinant protein were immunoprecipi-
tated with anti-Drf1 antibodies (lanes 7–11). Extracts containing wild-type His6-Claspin-FLAG were also mock
immunoprecipitated with control antibodies (lane 12). Lanes 2–6 depict 2% of the pre-IP extracts supple-
mented with the recombinant proteins listed above. Lane 1 shows an aliquot of interphase extract alone. The
immunoprecipitates were immunoblotted with anti-FLAG and anti-Drf1 antibodies. B, interphase, nuclei-
free egg extracts containing GST-XeClaspin(856–67), GST-HuClaspin-CKBD1, GST-HuClaspin-CKBD2, GST-
HuClaspin-CKBD3, and GST were immunoprecipitated with anti-Drf1 antibodies (lanes 7–11). Extracts containing
GST-Claspin(856–867) andGST-HuCKBD1were alsomock immunoprecipitatedwith control antibodies (lanes
12 and13). Lane1 contains analiquotof pre-IP interphaseextract, and lanes 2–6depict 2%of thepre-IP extracts
supplementedwith the recombinant proteins listed above. The immunoprecipitates were immunoblotted for
Drf1, Cdc7, and GST. C, a sequence alignment of the CKBD repeat sequences across a selection of metazoan
Claspin homologs. The organisms represented here are X. laevis (South African claw-toed frog), Gallus gallus
(domestic chicken),Drosophilamelanogaster (fruit fly),Homo sapiens (human),Bos taurus (domestic cow),Canis
familiaris (domestic dog),Monodelphis domestica (gray short-tailed opossum), Rattus norvegicus (Norway rat),
Musmusculus (housemouse), andDanio rerio (zebrafish). Thearrowspoint to theX. laevisClaspinCKBD repeats,
and the arrowheads point to the H. sapiens CKBD repeats. Asterisks denote positions that are conserved in all
CKBD repeats. Diamonds indicate crucial residues for binding of DDK, and crosses denote the CKBD repeats in
X. laevis and H. sapiens that associate with DDK.
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of DDK interaction mutants in the context of the GST-fused
776–1078 Claspin peptide fragment mentioned previously.
This peptide fragment of Claspin contains both the CKBD and
additional sequences necessary for rescuing the activation of
Chk1 in Claspin-depleted extracts (24).
When we used glutathione beads to isolate the wild-type,
D861E,Q866K, and E/Kmutant Claspin (776–1078) fragments
from nuclei-free interphase extracts, we found that all of these
proteins could bind Chk1 in extracts that had been treated with
the checkpoint-inducing (dA)70-(dT)70 oligonucleotides (Fig.
4A). Notably, the mutant Claspin fragments displayed a reduc-
tion in electrophoretic mobility equivalent to that of the wild-
type fragment in extracts treated with (dA)70-(dT)70 (Fig. 4A).
This electrophoretic shift is characteristic of Claspin peptides
containing the CKBD and is mediated by phosphorylation in
response to checkpoint activation (24, 42).
Next, we tested the Claspin-Chk1 interaction in a reciprocal
manner by incubating glutathione beads in extracts supple-
mented with both a GST-tagged version of Chk1 (Chk1-GST-
His6) and the different versions of the full-length His6-Claspin-
FLAG protein. By this methodology, we also observed that
D861E,Q866K, and E/Kmutants could associate normally with
Chk1 (Fig. 4B). Taken together, these results indicate that elim-
ination of the ability of Claspin to associate with DDK has vir-
tually no effect on binding to Chk1.
Subsequently, we endeavored to
test whether Claspin fragments
that are unable to bind to Chk1
were still competent to interact
with DDK. Chk1 interacts with
Claspin through two phospho-
serines (Ser(P)864 and Ser(P)895)
that become phosphorylated in
response to activation of the DNA
replication checkpoint (42). We
performed anti-Drf1 immunopre-
cipitations with interphase extracts
supplemented with CKBD-contain-
ing GST-fused Claspin fragments
(847–903) that were either wild type
or had Ser864 and Ser895 mutated to
alanines (designated as the 2AG
mutant). The wild-type and 2AG
fragments were found at equivalent
levels in the anti-Drf1 immunopre-
cipitates, regardless of whether the
extracts contained the checkpoint-
inducing (dA)70-(dT)70 oligonucleo-
tides (Fig. 4C and supplemental
Fig. S5). Thus, the binding of Chk1 to
Claspin is distinct from the interac-
tion of DDKwith Claspin.
Next, we tested whether amutant
version of Claspin that was compro-
mised for interacting with DDKwas
competent to activate Chk1 in re-
sponse to replication arrest. To
address this question, we immu-
nodepleted Claspin from extracts and then added back wild-
type or mutant full-length His6-Claspin-FLAG proteins to
approximately endogenous levels. The extracts were incubated
with demembranated sperm chromatin in the absence or pres-
ence of aphidicolin. The activation of Chk1wasmonitoredwith
anti-phosphopeptide antibodies that detect phosphorylation of
Chk1 on Ser344, a well established marker for activation of this
kinase. As expected, activation of Chk1 in response to aphidi-
colin was ablated in the absence of Claspin, and recombinant
wild-type Claspin could reverse this defect (Fig. 5A, lanes 8 and
9). Significantly, the E/K mutant Claspin protein was also fully
able to rescue the activation of Chk1 (Fig. 5A, lane 10). The
D861E mutant Claspin protein had similar efficacy as the E/K
protein for activating Chk1 (data not shown). These results are
entirely consistent with the fact that these mutants can still
bind Chk1 normally.
Claspin associates with chromatin during the S phase in a
manner that depends on both the prereplication complex and
Cdc45 (23). Themost important known kinase target of DDK is
the MCM2–7 complex, and this phosphorylation leads to the
recruitment of Cdc45 (9–11). Accordingly, we examined the
ability of the DDK interaction mutants of Claspin to associate
with chromatin that is undergoing replication in egg extracts.
For this purpose, we isolated chromatin from extracts in which
we had immunodepleted the endogenous Claspin and replaced
FIGURE 4. Interactions of Claspin with DDK and Chk1 have distinct requirements. A, interphase extracts,
lacking or containing (dA)70-(dT)70 (pA-pT), were supplemented with wild-type GST-Claspin(776–1078), GST-
Claspin(776–1078)-Q866K, GST-Claspin(776–1078)-D861E, GST-Claspin(776–1078)-E/K, andGST. The extracts
were subjected to pulldowns with glutathione-agarose beads (lanes 3–12). Lanes 13–17 depict 2% of the
prepulldown extracts supplemented with the above recombinant peptides. Lanes 1 and 2 depict extracts
without and with oligonucleotides but with no added recombinant proteins. The pulldown fractions were
immunoblotted for Chk1 and GST. B, interphase extracts, lacking or containing (dA)70-(dT)70 (pA-pT), were
supplemented with recombinant Chk1-GST-His6. The extracts were also supplemented with the indicated
versions of recombinant His6-Claspin-FLAG or no recombinant Claspin. The extracts were subjected to pull-
downs with glutathione-agarose beads (lanes 3–12). Lanes 13–17 depict 2% of the extracts prior to the pull-
downs. Lanes 1 and 2 depict extracts without and with oligonucleotides but with no added recombinant
proteins. The samples were immunoblotted for the FLAG epitope and GST. C, interphase extracts containing
GST-Claspin(776–851), wild-type GST-Claspin(847–903), GST-Claspin(847–903)-2AG, and GST-Claspin(847–
962) were incubated in the absence or presence of checkpoint-inducing oligonucleotides and immunopre-
cipitated with anti-Drf1 antibodies (D) or mock (M) control antibodies. The immunoprecipitates were immu-
noblotted for Drf1 and GST.
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it with wild-type recombinant Claspin or various DDK interac-
tionmutants. For these experiments, we also incubated the var-
ious extracts in the absence or presence of aphidicolin. We
observed that, in the absence of aphidicolin, both the D861E
and E/Kmutants bound to chromatin as efficiently as wild-type
Claspin (Fig. 5B). In the presence of aphidicolin, Claspin binds
in elevated amounts to chromatin and undergoes an electro-
phoretic shift caused by checkpoint-dependent phosphoryla-
tion. We found that both the D861E and E/K mutants, like
wild-type Claspin, associated in higher amounts with aphidico-
lin-treated chromatin and displayed a checkpoint-dependent
shift in electrophoretic mobility (Fig. 5B). Finally, our labora-
tory previously observed that Cdc45 accumulates in higher
amounts on chromatin in the absence of Claspin (23, 34). The
addition of recombinant wild-type Claspin reduced the binding
of Cdc45 to normal levels (Fig. 5B). Likewise, both the D861E
and E/K mutant Claspin proteins could elicit the normal bind-
ing pattern ofCdc45. Taken together, these results indicate that
Claspin can associate normally with chromatin under a variety
of different conditions, even if it has lost the ability to interact
with DDK.
The Interaction of Claspin with DDK Is Required for Main-
taining a Normal Rate of DNA Replication—Claspin is a regu-
lator of replication in mammalian cells and is required for a
normal rate of DNA replication, even under unperturbed con-
ditions (23, 24, 26, 27). However, in Xenopus egg extracts,
immunodepletion of Claspin results in only a very modest
decrease in DNA replication (23). Because the primary role
established forDDK is as an S phase regulator, we examined the
status of DNA replication in egg extracts containing the D861E
and E/K Claspin mutant proteins. To this end, we immunode-
pleted Claspin from interphase extracts and added back either
buffer alone or various recombinant His6-Claspin-FLAG pro-
teins. We measured DNA replication by adding [-32P]dATP
before the onset of replication and taking samples at selected
time points until replication typically reaches completion. Rep-
lication usually starts at 35–45 min after entry into inter-
phase in Xenopus egg extracts. We found that under these con-
ditions Claspin-depleted extracts with no recombinant protein
added (buffer alone) did not display a consistent decrease in
replication in comparison with mock depleted extracts or
Claspin-depleted extracts reconstituted with wild-type Claspin
(Fig. 6). However, when the D861E and E/K mutants were
FIGURE5.DDK interactionmutants of Claspin can stillmediate activation
of Chk1 and associate with replicating chromatin. A, nuclei were isolated
from interphase extracts supplementedwith 3,000 spermnuclei/l thatwere
either immunodepletedwith anti-Claspin antibodies (lanes 4–6 and 8–10) or
mockdepletedwith control antibodies (lanes 7and11). Theextractswerealso
incubated in the absence (lanes 4–7) or presence of aphidicolin (lanes 8–11).
The extracts were supplemented with full-length versions of wild-type His6-
Claspin-FLAG (lanes 5 and 9), His6-Claspin-FLAG-E/K (lanes 6 and 10), or no
recombinant protein (lanes 4 and 8). Lanes 12–15 depict 4% of the extracts
takenbefore isolationof nuclei. Aliquots of extractswere takenbefore (lane 1)
and after immunodepletion (lanes 2 and 3). The extracts and nuclear fractions
were immunoblotted forClaspin,Drf1,Mcm2,phosphorylatedSer344 of Chk1,
and Chk1. B, chromatin was isolated from interphase extracts supplemented
with 3,000 sperm nuclei/l and incubated in the absence (lanes 4–8) or pres-
ence of aphidicolin (lanes 9–13). The extracts were immunodepleted with
either anti-Claspin (lanes 4–7 and 9–12) or control antibodies (lanes 8 and 13).
The extracts were also supplementedwith the indicated versions of the His6-
Claspin-FLAG protein (lanes 5–7 and 10–12) or buffer alone (lanes 4, 8, 9, and
13). Lanes 14–18 depict 4%of the extract taken before isolation of chromatin.
Aliquots of extract were taken before (lane 1) and after immunodepletion
(lanes 2 and 3). The samples were immunoblotted for Claspin, Cdc45, and
Orc2.
FIGURE 6. Egg extracts containing DDK interaction mutants of Claspin
replicate chromosomal DNAmore slowly. Claspin-depleted extracts were
prepared and supplemented with recombinant wild-type (WT, closed
squares), D861E (open triangles), or E/K (asterisks) His6-Claspin-FLAG proteins
or buffer alone (open circles). Recombinant Claspin proteins were added back
at approximately the concentration of endogenous Claspin in egg extracts
(see supplemental Fig. S6). Mock depleted extracts (closed diamonds) were
prepared in parallel. Aliquots of extracts were taken at 35, 55, 75, and 95 min
andassayed for chromosomalDNA replication. Incorporationof 32P into chro-
mosomal DNA was determined by agarose gel electrophoresis and phos-
phorimaging. Incorporation was normalized to the level observed in the
mockdepleted extracts at 95min. The data points represent themeans S.E.
for seven independent experiments.
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added back to Claspin-depleted extracts, there was an approx-
imately 30% decrease in replication (Fig. 6 and supple-
mental Fig. S6). The different rates of replication are apparent
even by the second time point (i.e. at 60 min). Thus, these
mutants appear to be having a negative effect on replication.
These results are consistent with the involvement of Claspin in
maintaining a normal basal replication rate in other systems
(24, 25, 27) and suggest that DDK may play a part in this
regulation.
DISCUSSION
The role of Claspin as a mediator in the activation of Chk1 in
response to replication stress has been well studied. On the
other hand, the role of Claspin as a regulator of replication is
still being elucidated. In this study, we have confirmed that
Claspin associates specifically with the replication-initiating
kinase DDK inXenopus egg extracts. A similar finding has been
made in human cells (37). Moreover, this complex includes
Claspin, Cdc7, Drf1, and the cohesin-loading protein Scc2. The
discovery that Claspin can be co-immunoprecipitated with
Scc2 coincides with the finding that the Drf1-Cdc7 complex
interacts with Scc2 and is necessary for the loading of Scc2 onto
chromatin during the S phase (41). Even though we did not
observe a defect in the loading of Scc2 onto chromatin in
Claspin-depleted extracts with no perturbation of replication
(data not shown), it remains possible that Claspin may play a
role in regulating the increased loading of the cohesin complex
onto chromatin in the presence of stalled replication forks (46).
We found that the minimal sequence of Claspin required for
binding toDDKwas the first repeat of theCKBD. By comparing
CKBD repeat sequences both within Xenopus Claspin and
between other metazoan Claspin homologs, we identified two
amino acid positions of maximum variability within the re-
peats. By changing aspartate 861 to glutamate and glutamine
866 to lysine (thereby converting the first Xenopus CKBD
repeat into the second), we were able to abolish almost com-
pletely the ability ofClaspin to interactwithDrf1.We examined
the evolutionary conservation of this binding by testing the
ability of GST-fused human CKBDminimal repeat peptides to
interact with Xenopus Drf1. There are three human CKBD
repeats, but only the first two are required for activation of
Chk1 (44, 45). The first human CKBD repeat, which has an
aspartate at the position equivalent to aspartate 861 ofXenopus
Claspin, was the only fragment that could interact with Xeno-
pus Drf1 in egg extracts. Although this is an admittedly heter-
ologous interaction, there is a high degree of sequence identity
between CKBD repeats across metazoan species. The first
repeat seems to contain aspartic acid at this position in nearly
every case (except zebrafish), whereas the other repeats have a
higher variability of residues, and none contain aspartic acid.
Therefore, it seems reasonable to speculate that there is a high
degree of conservation across metazoan Claspin molecules for
this site to interact with DDK.
The mechanism by which Claspin activates Chk1 has been
well described in Xenopus egg extracts. In response to replica-
tion stress, serines 864 and 895 are phosphorylated in an ATR-
dependent manner by an unidentified kinase. These phospho-
serines associate with the kinase domain of Chk1 during a
process that ultimately leads to the activation of Chk1 (22, 42,
47). The proximity of aspartate 861 and glutamine 866 to serine
864 was striking and led us to test whether the D861E or E/K
mutants would affect the ability of Claspin to activate Chk1.
Subsequently, we found that these mutants were fully compe-
tent to associate with Chk1 and mediate its activation in
response to replication stress. Additionally, a 2AGmutant ver-
sion of Claspin fragment that is incapable of binding to Chk1
(because of mutations in serines 864 and 895) was still able to
interact with Drf1. These findings suggest that the role of
Claspin in interacting with DDK is distinct from that of activat-
ing Chk1. It has been reported that the ablation of Cdc7 by
small interfering RNA leads to reduced activation of the ATR-
Chk1 pathway in mammalian cells (37). However, this effect
may be the result of a reduced number of replication forks as a
result of the absence of Cdc7 rather than a direct modulation of
Claspin. Other work has shown that overexpression or ectopic
addition of excess Dbf4-Cdc7 can lead to an attenuation of
Chk1 signaling upon the addition of etoposide in mammalian
cells and Xenopus egg extracts (36). Although we observed no
defect in the ability of the DDK interaction mutants to activate
Chk1 in response to aphidicolin, it remains possible that there
could be a defect in recovery fromdamage because of the loss of
interaction with DDK. Additionally, there could be differences
between the Dbf4-Cdc7 and Drf1-Cdc7 complexes or in
response to different types of damage.
On the other hand, our experiments indicate that addition of
the D861E and E/K mutants of Claspin to Claspin-depleted
extracts results in a slower rate of DNA replication in compar-
ison with Claspin-depleted extracts (23). There is also amodest
delay in mitosis in the presence of these mutants (data not
shown), which would be consistent with delayed replication.
Although Claspin and its yeast homolog Mrc1 are not abso-
lutely required for replication, these proteins are involved in the
control of replication-related processes. Our results suggest
that the inability of Claspin to associate with DDK normally
results in the perturbation of DNA replication.
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